Dharmacon

Website: http://www.dharmacon.com
Type of Company: Life Sciences
Company Status: Realized
Business: Leading supplier worldwide of synthetic RNA
Outcome: Sold to Fisher Scientific (NYSE:FSH) March, 2004.
Co-investors: Telegraph Hill Partners